Prognostic value of the systemic immune-inflammation index in acute limb ischemia undergoing endovascular therapy
Frontiers in Cardiovascular Medicine · 12.08.2026 · 13
DOI: 10.3389/fcvm.2026.1732152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 12.08.2026. Verfasst von Shuji Morikawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Chutoen General Medical Center, Kakegawa, Shizuoka, Japan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute limb ischemia (ALI) is a vascular emergency associated with major amputation and mortality, highlighting the need for early risk stratification. The systemic immune-inflammation index (SII), calculated from platelet, neutrophil, and lymphocyte counts, is a composite biomarker reflecting systemic inflammation and immune status. Although SII has demonstrated prognostic value in various cardiovascular diseases, its role in patients with ALI undergoing endovascular therapy remains unclear.
Objective
To evaluate the association between baseline SII and 12-month outcomes in patients with ALI undergoing endovascular therapy.
Methods
This retrospective, single-center cohort study included 47 consecutive patients with ALI treated with endovascular therapy. Patients were dichotomized at the median baseline SII into high and low SII groups. The primary outcome was a composite of major amputation or all-cause mortality within 12 months. Kaplan–Meier survival analysis and multivariable Cox proportional hazards regression models were performed to assess associations between baseline SII and outcomes, adjusting for age, sex, severe ischemia (Rutherford IIb–III), and renal function (eGFR). Receiver operating characteristic analysis evaluated the discriminatory ability of SII.
Results
The primary outcome occurred in 20 patients (42.6%) and was more frequent in the high-SII group than in the low-SII group (62.5% vs. 21.7%, P = 0.008). Kaplan–Meier analysis demonstrated a higher event rate in the high-SII group (log-rank test, P = 0.002). In an exploratory multivariable Cox model, older age and high SII were associated with the primary composite outcome, although the estimate for high SII was imprecise with a wide confidence interval. Receiver operating characteristic analysis showed an area under the curve of 0.81 for SII, and exploratory comparisons did not demonstrate superiority of SII over the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, or C-reactive protein.
Conclusion
In this exploratory cohort study, elevated baseline SII was associated with a higher risk of the composite outcome of major amputation or all-cause mortality within 12 months in patients with ALI undergoing endovascular therapy. This association appeared to reflect overall adverse prognosis, whereas its specific association with major amputation remains uncertain. These findings, including the ROC-based analyses, should be considered hypothesis-generating and require validation in larger prospective multicenter studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Chutoen General Medical Center, Kakegawa, Shizuoka, Japan.
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Zitieren
APA
Morikawa, S., Takahashi, N., Ohinata, R., Mishina, T., Hayakawa, H., Kumihashi, Y., Inoue, N., Takayama, Y., & Murohara, T. (2026). Prognostic value of the systemic immune-inflammation index in acute limb ischemia undergoing endovascular therapy. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1732152
Vancouver
Morikawa S, Takahashi N, Ohinata R, Mishina T, Hayakawa H, Kumihashi Y, et al. Prognostic value of the systemic immune-inflammation index in acute limb ischemia undergoing endovascular therapy. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1732152
BibTeX
@article{Morikawa2026,
author = {Morikawa, Shuji and Takahashi, Nao and Ohinata, Ryo and Mishina, Takashi and Hayakawa, Hikaru and Kumihashi, Yuki and Inoue, Naoya and Takayama, Yohei and Murohara, Toyoaki},
title = {Prognostic value of the systemic immune-inflammation index in acute limb ischemia undergoing endovascular therapy},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1732152}
}
EUVIMED